Sinohealth Holdings Limited (2361.HK)
- Previous Close
5.360 - Open
5.360 - Bid 5.070 x --
- Ask 5.370 x --
- Day's Range
5.360 - 5.380 - 52 Week Range
3.500 - 6.000 - Volume
4,000 - Avg. Volume
1,200 - Market Cap (intraday)
2.309B - Beta (5Y Monthly) --
- PE Ratio (TTM)
20.65 - EPS (TTM)
0.260 - Earnings Date --
- Forward Dividend & Yield 0.07 (1.35%)
- Ex-Dividend Date Jun 24, 2024
- 1y Target Est
--
Sinohealth Holdings Limited provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally. The company operates through four segments: Smart Retail Cloud, Smart Decision Cloud, Smart Health Management Cloud, and Smart Medical Cloud. It engages in the research and development and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) product; research and development and the operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of innovative medicine; operation of SaaS products; provision of internet information and internet data center services; and engages in foreign-related market research business. The company also offers precision marketing solutions; and consulting and marketing services. It serves various fields, such as pharmaceutical industry, retail pharmacies, and physical examination and hospitals. The company was founded in 2007 and is headquartered in Guangzhou, China.
ir.sinohealth.cn759
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 2361.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2361.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2361.HK
Valuation Measures
Market Cap
2.31B
Enterprise Value
1.82B
Trailing P/E
20.76
Forward P/E
27.55
PEG Ratio (5yr expected)
4.44
Price/Sales (ttm)
5.34
Price/Book (mrq)
3.04
Enterprise Value/Revenue
4.59
Enterprise Value/EBITDA
15.16
Financial Highlights
Profitability and Income Statement
Profit Margin
25.75%
Return on Assets (ttm)
6.09%
Return on Equity (ttm)
14.49%
Revenue (ttm)
396.19M
Net Income Avi to Common (ttm)
102.03M
Diluted EPS (ttm)
0.260
Balance Sheet and Cash Flow
Total Cash (mrq)
467.96M
Total Debt/Equity (mrq)
2.03%
Levered Free Cash Flow (ttm)
12.81M
Company Insights: 2361.HK
2361.HK does not have Company Insights